Speaking panel: London Microbiome Meeting - Monday 3rd October 2022
Professor Eran Elinav - Weizmann Institute of Science
Prof. Eran Elinav, M.D., Ph.D. is a professor heading the Department of Systems Immunology, Weizmann Institute of Science, Israel, and the director of the Microbiome & Cancer division, National German Cancer Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany. Elinav has published more than 220 publications in leading peer-reviewed journals, focusing on host-microbiome interactions, and was awarded multiple prestigious international awards for his discoveries including Claire and Emmanuel G. Rosenblatt award from the American Physicians for Medicine, the Alon Foundation award, the Rappaport prize for biomedical research, the Levinson award for basic science research, the Landau prize.
Twitter: @EranElinav
Prof. Eran Elinav, M.D., Ph.D. is a professor heading the Department of Systems Immunology, Weizmann Institute of Science, Israel, and the director of the Microbiome & Cancer division, National German Cancer Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany. Elinav has published more than 220 publications in leading peer-reviewed journals, focusing on host-microbiome interactions, and was awarded multiple prestigious international awards for his discoveries including Claire and Emmanuel G. Rosenblatt award from the American Physicians for Medicine, the Alon Foundation award, the Rappaport prize for biomedical research, the Levinson award for basic science research, the Landau prize.
Twitter: @EranElinav
Professor Peter J. Turnbaugh - University of California, San Francisco
Peter J. Turnbaugh, Ph.D., is a Professor in the Department of Microbiology & Immunology, the G.W. Hooper Research Foundation, and the Benioff Center for Microbiome Medicine at the University of California, San Francisco. He is also a CZ Biohub Investigator. His research group uses interdisciplinary approaches in preclinical models and human cohorts to study the mechanisms through which the gut microbiome influences nutrition and pharmacology.
Twitter: @PTurnbaugh
Peter J. Turnbaugh, Ph.D., is a Professor in the Department of Microbiology & Immunology, the G.W. Hooper Research Foundation, and the Benioff Center for Microbiome Medicine at the University of California, San Francisco. He is also a CZ Biohub Investigator. His research group uses interdisciplinary approaches in preclinical models and human cohorts to study the mechanisms through which the gut microbiome influences nutrition and pharmacology.
Twitter: @PTurnbaugh
Professor Laure Bindels - UCLouvain
Laure Bindels is an Assistant Professor at UCLouvain. After a license in pharmaceutical sciences, she did her PhD as FNRS fellow in the Metabolism and Nutrition Research Group (UCLouvain), initiating a research project on gut microbiota and metabolic disorders related to cancer. During her postdoctoral stay at the University of Nebraska-Lincoln, USA, she studied the role of the gut microbiota in the metabolic benefits of resistant starches. Prof. Bindels’ lab is dedicated to the exploration of the metabolic pathways linking the gut microbiota, cancer and associated cachexia and inflammation, using metabolomics, next-generation sequencing and phenotyping.
Twitter: @Laure_Bindels
Laure Bindels is an Assistant Professor at UCLouvain. After a license in pharmaceutical sciences, she did her PhD as FNRS fellow in the Metabolism and Nutrition Research Group (UCLouvain), initiating a research project on gut microbiota and metabolic disorders related to cancer. During her postdoctoral stay at the University of Nebraska-Lincoln, USA, she studied the role of the gut microbiota in the metabolic benefits of resistant starches. Prof. Bindels’ lab is dedicated to the exploration of the metabolic pathways linking the gut microbiota, cancer and associated cachexia and inflammation, using metabolomics, next-generation sequencing and phenotyping.
Twitter: @Laure_Bindels
Short talks
Dr Adriel Latorre-Pérez - Darwin Bioprospecting Excellence S.L
Adriel Latorre-Pérez holds a PhD in Biomedicine and Biotechnology from the University of Valencia, doing his doctoral thesis at Darwin Bioprospecting Excellence S.L. (Valencia), in the framework of an Industrial Doctorate programme. The research topic of his thesis was the application of portable next-generation sequencing technologies (Oxford Nanopore Technologies) to the study of microbiomes of industrial/biotechnological relevance.
Twitter: @Adriiiel2s
Adriel Latorre-Pérez holds a PhD in Biomedicine and Biotechnology from the University of Valencia, doing his doctoral thesis at Darwin Bioprospecting Excellence S.L. (Valencia), in the framework of an Industrial Doctorate programme. The research topic of his thesis was the application of portable next-generation sequencing technologies (Oxford Nanopore Technologies) to the study of microbiomes of industrial/biotechnological relevance.
Twitter: @Adriiiel2s
Dr Mary E. Kable - University of California, Davis
Assistant Professor Kable is currently using samples from human cohort and dietary intervention studies, performed in collaboration with investigators at the USDA-ARS, Western Human Nutrition Research Center, to investigate how foods rich in complex carbohydrates and polyphenols can influence the structure of the adult gut microbial community, fermentation dynamics, and colonization resistance to pathogenic microbes.
Assistant Professor Kable is currently using samples from human cohort and dietary intervention studies, performed in collaboration with investigators at the USDA-ARS, Western Human Nutrition Research Center, to investigate how foods rich in complex carbohydrates and polyphenols can influence the structure of the adult gut microbial community, fermentation dynamics, and colonization resistance to pathogenic microbes.
Dr Francesco Asnicar - University of Trento
Dr Francesco Asnicar is a postdoc researcher at the Segata Lab (Department CIBIO, University of Trento, Italy) and his main research interests focus on the study of the relationships between the human gut microbiome and diet and developing new analysis tools to characterize unknown microbial organisms.
Twitter: @fasnicar
Dr Francesco Asnicar is a postdoc researcher at the Segata Lab (Department CIBIO, University of Trento, Italy) and his main research interests focus on the study of the relationships between the human gut microbiome and diet and developing new analysis tools to characterize unknown microbial organisms.
Twitter: @fasnicar